Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox (CLX) to $119 from $129 and keeps an Underweight rating on the shares. The firm adjusted price targets in the staples group as a part of a Q2 preview. Investor expectations “feel subdued” into earnings season, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $135 from $140 at Citi
- Clorox price target lowered to $135 from $142 at Wells Fargo
- Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
- Clorox using generative AI for ad creation, WSJ reports
- Clorox price target lowered to $145 from $167 at Jefferies